全文获取类型
收费全文 | 7330篇 |
免费 | 710篇 |
国内免费 | 2篇 |
出版年
2023年 | 29篇 |
2022年 | 80篇 |
2021年 | 163篇 |
2020年 | 92篇 |
2019年 | 124篇 |
2018年 | 126篇 |
2017年 | 115篇 |
2016年 | 218篇 |
2015年 | 351篇 |
2014年 | 379篇 |
2013年 | 474篇 |
2012年 | 565篇 |
2011年 | 561篇 |
2010年 | 348篇 |
2009年 | 317篇 |
2008年 | 456篇 |
2007年 | 427篇 |
2006年 | 395篇 |
2005年 | 342篇 |
2004年 | 311篇 |
2003年 | 287篇 |
2002年 | 258篇 |
2001年 | 95篇 |
2000年 | 96篇 |
1999年 | 94篇 |
1998年 | 74篇 |
1997年 | 54篇 |
1996年 | 53篇 |
1995年 | 32篇 |
1994年 | 28篇 |
1993年 | 36篇 |
1992年 | 51篇 |
1991年 | 53篇 |
1990年 | 54篇 |
1989年 | 55篇 |
1988年 | 48篇 |
1987年 | 33篇 |
1986年 | 43篇 |
1985年 | 37篇 |
1983年 | 27篇 |
1982年 | 35篇 |
1980年 | 32篇 |
1979年 | 34篇 |
1978年 | 30篇 |
1976年 | 26篇 |
1975年 | 29篇 |
1974年 | 38篇 |
1973年 | 31篇 |
1971年 | 27篇 |
1968年 | 26篇 |
排序方式: 共有8042条查询结果,搜索用时 15 毫秒
1.
Minh C. Nguyen Guang Huan Tu Kathryn E. Koprivnikar Melissa Gonzalez-Edick Karin U. Jooss Thomas C. Harding 《Cancer immunology, immunotherapy : CII》2010,59(9):1313-1323
A critical factor in clinical development of cancer immunotherapies is the identification of tumor-associated antigens that
may be related to immunotherapy potency. In this study, protein microarrays containing >8,000 human proteins were screened
with serum from prostate cancer patients (N = 13) before and after treatment with a granulocyte–macrophage colony-stimulating factor (GM-CSF)-secreting whole cell immunotherapy.
Thirty-three proteins were identified that displayed significantly elevated (P ≤ 0.05) signals in post-treatment samples, including three proteins that have previously been associated with prostate carcinogenesis,
galectin-8, T-cell alternative reading frame protein (TARP) and TNF-receptor-associated protein 1 (TRAP1). Expanded analysis
of antibody induction in metastatic, castration-resistant prostate cancer (mCRPC) patients (N = 92) from two phase 1/2 trials of prostate cancer immunotherapy, G-9803 and G-0010, indicated a significant (P = 0.03) association of TARP antibody induction and median survival time (MST). Antibody induction to TARP was also significantly
correlated (P = 0.036) with an increase in prostate-specific antigen doubling time (PSADT) in patients with a biochemical (PSA) recurrence
following prostatectomy or radiation therapy (N = 19) from in a previous phase 1/2 trial of prostate cancer immunotherapy, G-9802. RNA and protein encoding TARP and TRAP1
was up-regulated in prostate cancer tissue compared to matched normal controls. These preliminary findings suggest that antibody
induction to TARP may represent a possible biomarker for treatment response to GM-CSF secreting cellular immunotherapy in
prostate cancer patients and demonstrates the utility of using protein microarrays for the high-throughput screening of patient-derived
antibody responses. 相似文献
2.
3.
Shira Weingarten-Gabbay Susan Klaeger Siranush Sarkizova Leah R. Pearlman Da-Yuan Chen Kathleen M.E. Gallagher Matthew R. Bauer Hannah B. Taylor W. Augustine Dunn Christina Tarr John Sidney Suzanna Rachimi Hasahn L. Conway Katelin Katsis Yuntong Wang Del Leistritz-Edwards Melissa R. Durkin Christopher H. Tomkins-Tinch Pardis C. Sabeti 《Cell》2021,184(15):3962-3980.e17
- Download : Download high-res image (225KB)
- Download : Download full-size image
4.
5.
6.
Melissa A. Partridge Sumana Gopinath Simon J. Myers Jens R Coorssen 《Journal of chemical biology》2016,9(1):9-18
An initial proteomic analysis of the cuprizone mouse model to characterise the breadth of toxicity by assessing cortex, skeletal muscle, spleen and peripheral blood mononuclear cells. Cuprizone treated vs. control mice for an initial characterisation. Select tissues from each group were pooled, analysed in triplicate using two-dimensional gel electrophoresis (2DE) and deep imaging and altered protein species identified using liquid chromatography tandem mass spectrometry (LC/MS/MS). Forty-three proteins were found to be uniquely detectable or undetectable in the cuprizone treatment group across the tissues analysed. Protein species identified in the cortex may potentially be linked to axonal damage in this model, and those in the spleen and peripheral blood mononuclear cells to the minimal peripheral immune cell infiltration into the central nervous system during cuprizone mediated demyelination. Primary oligodendrocytosis has been observed in type III lesions in multiple sclerosis. However, the underlying mechanisms are poorly understood. Cuprizone treatment results in oligodendrocyte apoptosis and secondary demyelination. This initial analysis identified proteins likely related to axonal damage; these may link primary oligodendrocytosis and secondary axonal damage. Furthermore, this appears to be the first study of the cuprizone model to also identify alterations in the proteomes of skeletal muscle, spleen and peripheral blood mononuclear cells. Notably, protein disulphide isomerase was not detected in the cuprizone cohort; its absence has been linked to reduced major histocompatibility class I assembly and reduced antigen presentation. Overall, the results suggest that, like experimental autoimmune encephalomyelitis, results from the standard cuprizone model should be carefully considered relative to clinical multiple sclerosis. 相似文献
7.
Sign language studies of cross-fostered chimpanzees measure the effect of special rearing conditions on the development of
very young chimpanzees. Cross-fostered chimpanzees, like human children, develop gradually in a process that takes many years.
Here we discuss details of the procedure, the overlap between human and chimpanzee infants in the contents of the first 50-item
vocabularies, and the ways in which the signs of the chimpanzees exhibit the fuzziness of natural language categories. We
also compare the cross-fostering approach with more traditional modular approaches to the study of language-like behavior
in nonhuman animals.
Project Washoe was originally supported by grants MH-12154 from the National Institute of Mental Health and GB-7432 from the
National Science Foundation. We gratefully acknowledge this support and the support that later sign language studies of chimpanzees
have received since then from NIH, NSF, the National Geographic Society, the Grant Foundation, the Spencer Foundation, the
University of Nevada, and the UNR Foundation. 相似文献
8.
A method for identifying cysteine-containing peptides in proteins is presented using 2-bromoacetamido-4-nitrophenol (BNP) to introduce an easily detectable probe. The formation of a covalent bond between the protein sulfhydryl group and the acetamido moiety of BNP introduces a chromophore with an absorbance maximum at 410 nm. The modified protein can then be cleaved with appropriate proteases and the resulting peptides separated by chromatographic methods. Monitoring the effluent at a single wavelength (405 nm) provides a rapid and simple method of detecting and isolating only those peptides which contain cysteine residue(s). The nitrophenol derivative is stable under conditions required for protease cleavage. The reagent is therefore useful for locating cysteine-containing peptides in protein digests and can be used to explore the accessibility of different cysteines under a variety of conditions. The ease of modification, specificity of reaction, product stability, and simple detection of modified peptides make BNP ideal for investigation of cysteine residues. 相似文献
9.
10.